HealthInvest Partners’s La Jolla Pharmaceutical Company LJPC Stock Holding History

HealthInvest Partners’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,265,000	Closed	-$4.04M	–	13
2022 Q2	$4.04M	Buy	1,265,000 +558,000	+79%	+$2.17M	9.3%	2
2022 Q1	$3.02M	Sell	707,000 -123,000	-15%	-$536K	4.81%	10
2021 Q4	$3.86M	Buy	830,000 +560,000	+207%	+$2.33M	5.44%	9
2021 Q3	$1.08M	Buy	+270,000	New	+$1.07M	1.61%	17

HealthInvest Partners's LJPC Position: Q3 2022 in Review

HealthInvest Partners sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 1,265,000 shares — an estimated $4.04M sold.

HealthInvest Partners first reported a position in LJPC in Q3 2021 and held it in 4 quarters. The position peaked at $4.04M in Q2 2022. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

HealthInvest Partners reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
HealthInvest Partners sold 1,265,000 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $4.04M.
HealthInvest Partners first reported a position in La Jolla Pharmaceutical Company in Q3 2021 and held it in 4 quarters.
HealthInvest Partners's La Jolla Pharmaceutical Company position peaked at $4.04M in Q2 2022.
0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on HealthInvest Partners's 13F filing for Q3 2022, filed 21 Oct 2022.